These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35865413)
1. Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats. Kaye J; Reisine T; Finkbeiner S Fac Rev; 2022; 11():16. PubMed ID: 35865413 [TBL] [Abstract][Full Text] [Related]
2. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H Mol Brain; 2012 May; 5():17. PubMed ID: 22613578 [TBL] [Abstract][Full Text] [Related]
3. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease. Alkanli SS; Alkanli N; Ay A; Albeniz I Mol Neurobiol; 2023 Mar; 60(3):1486-1498. PubMed ID: 36482283 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. Jeon I; Choi C; Lee N; Im W; Kim M; Oh SH; Park IH; Kim HS; Song J Int J Stem Cells; 2014 May; 7(1):43-7. PubMed ID: 24921027 [TBL] [Abstract][Full Text] [Related]
7. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics. Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279 [TBL] [Abstract][Full Text] [Related]
8. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. Lu B; Palacino J FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320 [TBL] [Abstract][Full Text] [Related]
9. Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion. Kaye J; Reisine T; Finkbeiner S Fac Rev; 2021; 10():77. PubMed ID: 34746930 [TBL] [Abstract][Full Text] [Related]
10. Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease. Linville RM; Nerenberg RF; Grifno G; Arevalo D; Guo Z; Searson PC Fluids Barriers CNS; 2022 Jun; 19(1):54. PubMed ID: 35773691 [TBL] [Abstract][Full Text] [Related]
12. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015 [TBL] [Abstract][Full Text] [Related]
13. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin. Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904 [TBL] [Abstract][Full Text] [Related]
14. Huntington's Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support. Garcia VJ; Rushton DJ; Tom CM; Allen ND; Kemp PJ; Svendsen CN; Mattis VB Front Neurosci; 2019; 13():669. PubMed ID: 31316341 [TBL] [Abstract][Full Text] [Related]
16. iPSC-based drug screening for Huntington's disease. Zhang N; Bailus BJ; Ring KL; Ellerby LM Brain Res; 2016 May; 1638(Pt A):42-56. PubMed ID: 26428226 [TBL] [Abstract][Full Text] [Related]
17. Human-to-mouse prion-like propagation of mutant huntingtin protein. Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146 [TBL] [Abstract][Full Text] [Related]